Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease psoriasis
Symptom C0239946|hepatic fibrosis
Sentences 2
PubMedID- 23065020 In this study, we aimed to evaluate the effect of etanercept versus psoralen and uva (puva) therapy on the hepatic fibrosis risk in patients with psoriasis, metabolic syndrome, and nafld (with nafld diagnosed by ultrasonography).
PubMedID- 23440555 Insulin-related biomarkers and their relationship with hepatic fibrosis risk in patients with psoriasis, metabolic syndrome and non-alcoholic fatty liver disease.

Page: 1